Abnova (Taiwan) Corporation (4133.TW)
TWD 27.35
(3.6%)
TWD 27.35
(3.6%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.72 TWD | -41.94% |
| 2022 | 1.24 TWD | 163.83% |
| 2021 | 0.47 TWD | -21.67% |
| 2020 | 0.60 TWD | 1013.17% |
| 2019 | 0.05 TWD | -92.91% |
| 2018 | 0.76 TWD | -21.65% |
| 2017 | 0.97 TWD | 6.59% |
| 2016 | 0.91 TWD | 22.97% |
| 2015 | 0.74 TWD | -29.52% |
| 2014 | 1.05 TWD | -10.26% |
| 2013 | 1.17 TWD | -7.87% |
| 2012 | 1.27 TWD | -34.2% |
| 2011 | 1.93 TWD | -19.58% |
| 2010 | 2.40 TWD | 37.14% |
| 2009 | 1.75 TWD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 0.30 TWD | -31.82% |
| 2024 Q1 | 0.44 TWD | 144.44% |
| 2023 Q3 | 0.17 TWD | -15.0% |
| 2023 Q1 | 0.18 TWD | -10.0% |
| 2023 FY | - TWD | -41.94% |
| 2023 Q2 | 0.20 TWD | 11.11% |
| 2023 Q4 | 0.18 TWD | 5.88% |
| 2022 FY | - TWD | 163.83% |
| 2022 Q2 | 0.31 TWD | 6.9% |
| 2022 Q3 | 0.44 TWD | 41.94% |
| 2022 Q4 | 0.20 TWD | -54.55% |
| 2022 Q1 | 0.29 TWD | 1313.39% |
| 2021 Q2 | 0.11 TWD | -31.25% |
| 2021 Q1 | 0.16 TWD | 0.0% |
| 2021 Q4 | -0.02 TWD | -110.86% |
| 2021 FY | - TWD | -21.67% |
| 2021 Q3 | 0.22 TWD | 100.0% |
| 2020 Q3 | 0.25 TWD | 257.14% |
| 2020 FY | - TWD | 1013.17% |
| 2020 Q1 | 0.13 TWD | 239.43% |
| 2020 Q2 | 0.07 TWD | -46.15% |
| 2020 Q4 | 0.16 TWD | -36.0% |
| 2019 Q3 | 0.01 TWD | -75.0% |
| 2019 FY | - TWD | -92.91% |
| 2019 Q1 | -0.03 TWD | -112.88% |
| 2019 Q4 | 0.04 TWD | 283.0% |
| 2019 Q2 | 0.04 TWD | 229.45% |
| 2018 Q3 | 0.16 TWD | -23.81% |
| 2018 Q2 | 0.21 TWD | 50.0% |
| 2018 FY | - TWD | -21.65% |
| 2018 Q4 | 0.24 TWD | 50.0% |
| 2018 Q1 | 0.14 TWD | -36.36% |
| 2017 Q2 | 0.28 TWD | 40.0% |
| 2017 Q4 | 0.22 TWD | -21.43% |
| 2017 Q1 | 0.20 TWD | -28.57% |
| 2017 FY | - TWD | 6.59% |
| 2017 Q3 | 0.28 TWD | 0.0% |
| 2016 Q2 | 0.21 TWD | -12.5% |
| 2016 FY | - TWD | 22.97% |
| 2016 Q4 | 0.28 TWD | 100.0% |
| 2016 Q3 | 0.14 TWD | -33.33% |
| 2016 Q1 | 0.24 TWD | 41.18% |
| 2015 FY | - TWD | -29.52% |
| 2015 Q4 | 0.17 TWD | 13.33% |
| 2015 Q2 | 0.41 TWD | 4170.83% |
| 2015 Q3 | 0.15 TWD | -63.41% |
| 2015 Q1 | 0.01 TWD | -97.47% |
| 2014 Q3 | 0.27 TWD | 35.0% |
| 2014 FY | - TWD | -10.26% |
| 2014 Q4 | 0.38 TWD | 40.74% |
| 2014 Q2 | 0.20 TWD | -9.09% |
| 2014 Q1 | 0.22 TWD | 10.0% |
| 2013 Q3 | 0.25 TWD | -21.88% |
| 2013 Q4 | 0.20 TWD | -20.0% |
| 2013 FY | - TWD | -7.87% |
| 2013 Q1 | 0.40 TWD | 48.15% |
| 2013 Q2 | 0.32 TWD | -20.0% |
| 2012 Q3 | 0.31 TWD | 19.23% |
| 2012 FY | - TWD | -34.2% |
| 2012 Q4 | 0.27 TWD | -12.9% |
| 2012 Q2 | 0.26 TWD | -42.22% |
| 2012 Q1 | 0.45 TWD | -4.26% |
| 2011 Q3 | 0.46 TWD | 24.32% |
| 2011 Q4 | 0.47 TWD | 2.17% |
| 2011 FY | - TWD | -19.58% |
| 2011 Q1 | 0.63 TWD | 96.88% |
| 2011 Q2 | 0.37 TWD | -41.27% |
| 2010 Q1 | 0.68 TWD | 0.0% |
| 2010 FY | - TWD | 37.14% |
| 2010 Q3 | 0.66 TWD | -10.81% |
| 2010 Q4 | 0.32 TWD | -51.52% |
| 2010 Q2 | 0.74 TWD | 8.82% |
| 2009 FY | - TWD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Apex Biotechnology Corp. | 1.16 TWD | 37.931% |
| Sinphar Pharmaceutical Co.,Ltd. | 2.24 TWD | 67.857% |
| Panion & Bf Biotech Inc. | 0.90 TWD | 20.0% |
| Chunghwa Chemical Synthesis & Biotech Co., Ltd. | 3.42 TWD | 78.947% |
| GenMont Biotech Incorporation | 0.38 TWD | -89.474% |
| Adimmune Corporation | -1.52 TWD | 147.368% |
| Tanvex BioPharma, Inc. | -16.42 TWD | 104.385% |
| Polaris Group | -2.12 TWD | 133.962% |
| Energenesis Biomedical CO.,LTD. | -3.62 TWD | 119.89% |
| UnicoCell Biomed Co., Ltd. | -1.56 TWD | 146.154% |
| PELL Bio-Med Technology Co. Ltd. | -8.62 TWD | 108.353% |